Menopausal hormone therapy may accelerate tau buildup in older women

Drug commonly taken by middle-aged women linked to ‘worse Alzheimer’s outcomes’

A new study suggests that women who use a popular hormonal menopause treatment later in life may be at a higher risk of developing Alzheimer’s disease.

Menopause hormonal therapy found linked to Alzheimer’s risk

Researchers hope findings could help optimise menopausal treatment guidelines

Menopausal hormone therapy may accelerate tau buildup in older women

A new study from Mass General Brigham researchers has found faster accumulation of tau-a key indicator of Alzheimer's disease-in the brains of women over the age of 70 who took menopausal hormone therapy (HT) more than a decade before.

Hormone therapy among older women linked to tau accumulation, a hallmark of Alzheimer's disease

A new study by Mass General Brigham researchers has found faster accumulation of tau—a key indicator of Alzheimer's disease—in the brains of women over the age of 70 who took menopausal hormone therapy (HT) more than a decade before. The results, which are published in Science Advances, could help inform discussions between patients and clinicians about Alzheimer's disease risk and HT treatment.

Pourquoi la ménopause influence-t-elle la santé cardiaque ?

Pourquoi la santé cardiaque est-elle intimement liée à la ménopause chez les femmes ? Une question capitale à comprendre pour le bien-être féminin.

Women with intense menopause symptoms are more likely to show signs of dementia